Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-02-21 @ 2:43 PM
Study NCT ID:
NCT06511869
Status:
COMPLETED
Last Update Posted:
2025-07-04
First Post:
2024-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)
Sponsor:
Dizal Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DZ2021J0005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None